Fusion venture branches out into cancer therapy

Cancer therapy

An artist’s conception shows how a beam of neutrons could be directed at a tumor in a patient’s head, shown in a cutaway view. (TAE Life Sciences Illustration)

TAE Technologies, the California-based fusion energy company backed by Microsoft co-founder Paul Allen, has spawned a spinoff focusing on a novel type of cancer therapy.

The spinoff, TAE Life Sciences, is a majority-owned subsidiary of TAE Technologies and will take advantage of the company’s accelerator-based beam technology.

In its quest to tame nuclear fusion, TAE Technologies has developed a high-intensity beam system that shoots energetic particles at clouds of plasma to boost stability and performance.

TAE Life Sciences aims to use similar beams for an application known as boron neutron capture therapy, or BNCT. The technique involves injecting a drug containing non-radioactive boron into a cancer patient’s tumor, and then shooting a neutron beam at the tumor.

The boron atoms absorb the neutrons, resulting in a localized radiation effect that kills the tumor cells while preserving non-cancerous tissue.

Get the full story on GeekWire.

About Alan Boyle

Award-winning science writer, creator of Cosmic Log, author of "The Case for Pluto: How a Little Planet Made a Big Difference," president of the Council for the Advancement of Science Writing. Check out "About Alan Boyle" for more fun facts.
This entry was posted in GeekWire and tagged , , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

w

Connecting to %s